GO:0006577 amino-acid betaine metabolic process: Methyl Donor Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006577 amino-acid betaine metabolic process describes the chemical reactions and pathways involving any betaine, the N-trimethyl derivative of an amino acid.
• Glycine betaine is the best-characterized member of this process and serves as a major organic osmolyte and methyl donor in humans and many other organisms.
• Betaine metabolism intersects with one-carbon metabolism, choline oxidation, methionine remethylation, and epigenetic regulation through S-adenosylmethionine.
• Key enzymes include betaine-homocysteine S-methyltransferase (BHMT), choline dehydrogenase (CHDH), and betaine aldehyde dehydrogenase (BADH/ALDH9A1).
• Disruption of betaine metabolism is linked to remethylation disorders, hyperhomocysteinemia, and altered lipid metabolism.
• CRISPR knockout, knock-in, and overexpression models are powerful tools for dissecting the causal roles of betaine metabolic genes in health and disease.
Description
GO:0006577 amino-acid betaine metabolic process is a biological process ontology term that encompasses the chemical reactions and pathways involving any betaine, defined as the N-trimethyl derivative of an amino acid. Betaines are zwitterionic compounds that function as organic osmolytes, methyl donors, and regulators of cellular volume and protein stability. The most abundant and extensively studied betaine in mammals is glycine betaine (trimethylglycine), which is derived from dietary sources or synthesized from choline via a two-step oxidation pathway. This process is critical for maintaining cellular homeostasis, particularly in the kidney, liver, and brain, where osmotic stress and methyl balance are tightly regulated. Research into amino-acid betaine metabolic process has gained momentum because of its connections to one-carbon metabolism, epigenetics, and human disease. Betaine serves as a methyl donor in the remethylation of homocysteine to methionine, a reaction catalyzed by betaine-homocysteine S-methyltransferase (BHMT). This links betaine metabolism directly to the methionine cycle and to the production of S-adenosylmethionine (SAM), the universal methyl donor for DNA and histone methylation. Consequently, perturbations in betaine metabolism can influence gene expression, lipid metabolism, and neurological function. For researchers, GO:0006577 provides a framework to study how cells and organisms handle betaine under normal and pathological conditions. The process is relevant to inherited remethylation disorders, cardiovascular disease, obesity, and cancer, and it is increasingly targeted in nutritional and pharmacological interventions. Understanding the enzymes, transporters, and regulatory mechanisms involved is essential for developing precise experimental models and therapeutic strategies.
amino-acid betaine metabolic process At A Glance
| GO ID | GO:0006577 |
|---|---|
| GO term | amino-acid betaine metabolic process |
| Ontology | biological_process |
| Synonym | betaine metabolic process, betaine metabolism |
| Definition | The chemical reactions and pathways involving any betaine, the N-trimethyl derivative of an amino acid. |
| Major function | Synthesis, interconversion, and utilization of betaines as osmolytes and methyl donors |
| Key enzymes | BHMT, CHDH, ALDH9A1 (BADH), and related methyltransferases |
| Related pathways | One-carbon metabolism, choline oxidation, methionine remethylation, lipid metabolism |
| Human disease relevance | Remethylation disorders, hyperhomocysteinemia, obesity, cardiovascular disease |
What Is GO:0006577?
In our own words, GO:0006577 amino-acid betaine metabolic process refers to the sum of biochemical reactions and pathways that synthesize, interconvert, transport, or degrade betaines, which are N-trimethyl derivatives of amino acids. This includes the oxidation of choline to glycine betaine, the transfer of a methyl group from betaine to homocysteine to form methionine and dimethylglycine, and the osmotic and methyl-donor functions of betaine within cells.
Why Is amino-acid betaine metabolic process Important in Cell Biology?
Amino-acid betaine metabolic process is important because betaines, particularly glycine betaine, are essential for cellular adaptation to osmotic stress and for maintaining methyl balance through the methionine cycle. Betaine acts as a methyl donor for the remethylation of homocysteine, and its metabolism is tightly linked to choline, folate, and vitamin B12 pathways. Dysregulation of this process has been implicated in inherited remethylation disorders, cardiovascular disease, and metabolic syndrome, making it a target for nutritional and pharmacological interventions.
• Maintains cellular osmolarity and protects proteins from denaturation under osmotic stress.
• Serves as a primary methyl donor for homocysteine remethylation, supporting methionine and SAM homeostasis.
• Links choline metabolism to epigenetic regulation via SAM-dependent methylation of DNA and histones.
• Dysregulation is associated with remethylation disorders and hyperhomocysteinemia.
• Betaine supplementation can modulate betaine concentration depending on MTHFR genotype.
• Plays a role in lipid metabolism and obesity regulation through amino acid derivatives.
• Relevant to plant stress responses, as exogenous glycine betaine affects photosynthetic capacity and hormone metabolism.
• Provides a model for studying amino acid secondary transporters that mediate betaine uptake.
• Offers opportunities for CRISPR-based functional genomics of metabolic and epigenetic pathways.
What Happens During amino-acid betaine metabolic process?
Choline oxidation to glycine betaine
In simple terms: The body converts choline into glycine betaine through two chemical steps.
In the first step, choline dehydrogenase (CHDH) oxidizes choline to betaine aldehyde. In the second step, betaine aldehyde dehydrogenase (ALDH9A1, also known as BADH) oxidizes betaine aldehyde to glycine betaine. This pathway is a major source of betaine in humans, especially when dietary betaine intake is low.
Betaine-dependent homocysteine remethylation
In simple terms: Betaine donates a methyl group to homocysteine, turning it into methionine.
Betaine-homocysteine S-methyltransferase (BHMT) catalyzes the transfer of a methyl group from glycine betaine to homocysteine, producing methionine and dimethylglycine. This reaction is a key alternative to folate-dependent remethylation and is particularly important in the liver and kidney.
Transport and cellular accumulation of betaine
In simple terms: Betaine must be moved into cells by specialized transporter proteins.
Betaine is taken up by cells through amino acid secondary transporters, including the betaine/GABA transporter (BGT1, SLC6A12) and other SLC family members. These transporters use ion gradients to drive betaine accumulation, which is essential for osmoprotection in the kidney medulla and other tissues.
Methyl group transfer to the methionine cycle
In simple terms: The methyl group from betaine enters the methionine cycle to make SAM, the cell's main methyl donor.
After BHMT-mediated remethylation, methionine is converted to S-adenosylmethionine (SAM), which serves as the methyl donor for numerous methylation reactions, including DNA and histone methylation. Thus, betaine metabolism directly influences epigenetic regulation and gene expression.
Betaine as an organic osmolyte
In simple terms: Betaine helps cells survive high salt or low water conditions by balancing osmotic pressure.
Glycine betaine accumulates in cells to counteract osmotic stress without interfering with protein function. This osmolyte role is conserved from bacteria to plants to mammals, and it is particularly important in the kidney, liver, and brain.
Key Genes Involved in GO:0006577 amino-acid betaine metabolic process
The following genes and proteins are central to amino-acid betaine metabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BHMT | Betaine-homocysteine S-methyltransferase; remethylates homocysteine using betaine | Target for hyperhomocysteinemia and remethylation disorders |
| CHDH | Choline dehydrogenase; oxidizes choline to betaine aldehyde | Rate-limiting step in betaine synthesis from choline |
| ALDH9A1 | Betaine aldehyde dehydrogenase; oxidizes betaine aldehyde to glycine betaine | Essential for betaine production; linked to osmoprotection |
| SLC6A12 | Betaine/GABA transporter; mediates betaine uptake | Studied for osmolyte transport and renal function |
| MTHFR | Methylenetetrahydrofolate reductase; folate cycle enzyme | Genotype influences betaine concentration after supplementation |
| MTR | Methionine synthase; folate-dependent homocysteine remethylation | Interacts with betaine pathway in one-carbon metabolism |
| MAT1A | Methionine adenosyltransferase; synthesizes SAM | Links betaine metabolism to methylation capacity |
| GNMT | Glycine N-methyltransferase; regulates SAM/SAH ratio | Modulates methyl balance and betaine utilization |
| PEMT | Phosphatidylethanolamine N-methyltransferase; synthesizes phosphatidylcholine | Connects choline/betaine metabolism to lipid metabolism |
| CBS | Cystathionine beta-synthase; transsulfuration of homocysteine | Affects homocysteine flux and betaine demand |
| SLC7A11 | Cystine/glutamate transporter; related to sulfur amino acid metabolism | Studied in context of sulfur amino acids and lipid metabolism |
| MTHFD1 | Methylenetetrahydrofolate dehydrogenase; folate metabolism | Influences one-carbon flux and betaine requirement |
| DNMT1 | DNA methyltransferase 1; maintains DNA methylation | Downstream effector of SAM produced via betaine metabolism |
| DNMT3A | DNA methyltransferase 3A; de novo methylation | Epigenetic reader of methyl donor status |
| HNF4A | Hepatocyte nuclear factor 4 alpha; transcription factor | Regulates expression of BHMT and other metabolic genes |
| PPARGC1A | PGC-1alpha; transcriptional coactivator | Linked to energy metabolism and betaine-related pathways |
| LEP | Leptin; regulates energy balance | Studied in obesity models involving amino acid derivatives |
| FTO | Fat mass and obesity-associated protein; demethylase | Connects methylation and obesity biology |
How Is amino-acid betaine metabolic process Regulated?
Amino-acid betaine metabolic process is regulated at multiple levels. Transcriptional regulation of BHMT and CHDH is influenced by hormonal and nutritional signals, including glucocorticoids and insulin. The methionine cycle and betaine utilization are also regulated by the availability of folate, vitamin B12, and choline, which determine the flux through remethylation pathways. Additionally, the SAM/SAH ratio serves as a metabolic sensor that modulates methyltransferase activity and epigenetic marks. In plants, exogenous glycine betaine and cycloleucine affect photosynthetic capacity and hormone metabolism, indicating that betaine metabolism is integrated with stress signaling.
amino-acid betaine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BHMT | Hyperhomocysteinemia, remethylation disorders | BHMT knockout mouse; cell lines with point mutations |
| MTHFR | Remethylation disorder, neural tube defects | MTHFR C677T knock-in cells; patient-derived iPSCs |
| CHDH | Choline deficiency, metabolic stress | CHDH knockout hepatocytes; overexpression in HEK293 |
| SLC6A12 | Osmotic stress, renal dysfunction | SLC6A12 knockout kidney cells; transport assays |
| PEMT | Lipid metabolism disorders, obesity | PEMT knockout mouse; CRISPR knock-in of variants |
Remethylation disorders and hyperhomocysteinemia
Inherited remethylation disorders, including defects in methionine synthase and methylenetetrahydrofolate reductase, can lead to hyperhomocysteinemia and neurological impairment. Betaine supplementation is used as a therapeutic strategy to provide an alternative methyl donor for homocysteine remethylation via BHMT. The first revision of guidelines for these disorders highlights the importance of betaine in clinical management.
Metabolic syndrome and obesity
Amino acid derivatives, including betaine, play roles in the regulation of obesity and lipid metabolism. Betaine metabolism intersects with pathways controlling energy balance, and dysregulation may contribute to metabolic syndrome. Sulfur-containing amino acids and their derivatives also influence lipid metabolism, further linking betaine to metabolic health.
Epigenetic regulation and cancer
Because betaine is a methyl donor for SAM synthesis, its metabolism can influence DNA and histone methylation, thereby affecting gene expression. Altered betaine metabolism may therefore contribute to epigenetic changes observed in cancer and other diseases, although direct causal evidence in humans remains an active area of research.
Plant stress and agricultural relevance
In plants such as Solanum melongena, exogenous glycine betaine and cycloleucine modulate photosynthetic capacity, amino acid composition, and hormone metabolism, suggesting that betaine metabolism is important for stress tolerance and crop productivity.
From amino-acid betaine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of BHMT impair homocysteine remethylation? | BHMT knockout cell line (e.g., HepG2) and mouse model |
| How do MTHFR variants affect betaine utilization? | MTHFR point-mutation knock-in cells; genotype-stratified supplementation study |
| What is the role of CHDH in choline oxidation? | CHDH overexpression and knockout in hepatocytes |
| How does SLC6A12 mediate betaine transport? | SLC6A12 tagged knock-in for imaging and transport assays |
| Does betaine metabolism influence lipid accumulation? | CRISPR knockout of PEMT or GNMT in adipocytes |
| Can betaine supplementation rescue remethylation defects? | Patient-derived fibroblasts with MTR or MTHFR mutations |
How to Study the amino-acid betaine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS metabolomics | Betaine, choline, dimethylglycine, methionine, homocysteine | Quantifying pathway flux in cells and plasma |
| NMR spectroscopy | Betaine and related metabolites | Non-invasive metabolic profiling |
| Genotyping (PCR, sequencing) | MTHFR, BHMT, CHDH variants | Assessing genetic influence on betaine status |
| DNA methylation arrays | Global and locus-specific methylation | Linking betaine metabolism to epigenetics |
| RNA-seq | Transcriptome changes | Identifying downstream effects of CRISPR edits |
| Proteomics | Protein abundance and modifications | Validating knockout or overexpression models |
| Betaine uptake assay | Transport kinetics | Characterizing SLC6A12 and other transporters |
| CRISPR screening | Gene essentiality and pathway interactions | Discovering novel regulators of betaine metabolism |
Metabolomics and targeted betaine quantification
Liquid chromatography-mass spectrometry (LC-MS) and nuclear magnetic resonance (NMR) can quantify betaine, choline, dimethylglycine, methionine, and homocysteine in cells and tissues. These methods are essential for assessing flux through amino-acid betaine metabolic process and for validating CRISPR models.
Genotyping and epigenetic profiling
Genotyping of MTHFR, BHMT, and related genes, combined with DNA methylation arrays or bisulfite sequencing, allows researchers to link betaine metabolism to epigenetic marks. Such studies have shown that MTHFR genotype modulates betaine concentration after supplementation.
Transcriptomics and proteomics
RNA-seq and quantitative proteomics can reveal changes in gene expression and protein abundance following CRISPR-mediated knockout or overexpression of betaine metabolic genes. These approaches help identify downstream pathways affected by altered betaine metabolism.
Transport and osmolyte assays
Radiolabeled or fluorescent betaine uptake assays in cell lines expressing SLC6A12 or other transporters measure transport kinetics and osmolyte accumulation. Such assays are critical for understanding the cellular handling of betaine.
How CRISPR Can Be Used to Study GO:0006577 amino-acid betaine metabolic process
Knockout
CRISPR knockout of BHMT, CHDH, or ALDH9A1 in cell lines such as HepG2 or HEK293 can abolish specific steps in amino-acid betaine metabolic process. These models are used to study the consequences of betaine depletion on homocysteine remethylation, methylation capacity, and osmotic stress responses.
Point Mutation
Point mutations in MTHFR (e.g., C677T) or BHMT can be introduced using CRISPR base editing or homology-directed repair to mimic human variants. Such models help determine how specific alleles affect betaine utilization and disease risk.
Knock-in
Knock-in of tagged versions of SLC6A12 or BHMT allows real-time imaging and biochemical purification of these proteins. Tagged knock-in models are valuable for studying transporter localization and protein-protein interactions in betaine metabolism.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of CHDH, BHMT, or ALDH9A1 can increase flux through betaine metabolic pathways. Overexpression models are used to test whether enhanced betaine synthesis or utilization protects against metabolic stress.
How EDITGENE Supports amino-acid betaine metabolic process Research
Researchers studying amino-acid betaine metabolic process-related genes often need to determine whether a candidate gene is causally involved in betaine homeostasis, homocysteine remethylation, or epigenetic regulation. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for amino-acid betaine metabolic process research.
Frequently Asked Questions About amino-acid betaine metabolic process
What is GO:0006577 amino-acid betaine metabolic process?
GO:0006577 is a Gene Ontology biological process term describing the chemical reactions and pathways involving any betaine, the N-trimethyl derivative of an amino acid.
What genes are involved in amino-acid betaine metabolic process?
Key genes include BHMT, CHDH, ALDH9A1, SLC6A12, MTHFR, and MTR, which mediate betaine synthesis, transport, and methyl transfer.
What is the role of betaine in the body?
Betaine acts as an organic osmolyte and a methyl donor for homocysteine remethylation, supporting methionine and SAM homeostasis.
How is betaine metabolism linked to epigenetics?
Betaine provides methyl groups for SAM synthesis, which is used for DNA and histone methylation, thereby influencing gene expression.
What diseases are associated with betaine metabolism?
Remethylation disorders, hyperhomocysteinemia, obesity, and cardiovascular disease have been linked to altered betaine metabolism.
Can betaine supplementation affect health?
Betaine supplementation can modulate betaine concentration depending on MTHFR genotype, but effects on amino acid profiles may be limited.
What enzymes catalyze betaine synthesis?
Choline dehydrogenase (CHDH) and betaine aldehyde dehydrogenase (ALDH9A1) catalyze the two-step oxidation of choline to glycine betaine.
How do cells transport betaine?
Betaine is transported by amino acid secondary transporters such as SLC6A12 (BGT1), which use ion gradients for uptake.
What model systems are used to study betaine metabolism?
CRISPR knockout, knock-in, and overexpression cell models, as well as mouse models, are commonly used to study betaine metabolic pathways.
Why is betaine important in plants?
In plants, glycine betaine acts as an osmoprotectant and can modulate photosynthetic capacity and hormone metabolism under stress.
Conclusion
GO:0006577 amino-acid betaine metabolic process is a fundamental biological process that connects osmolyte balance, one-carbon metabolism, and epigenetic regulation. Its dysregulation has been implicated in remethylation disorders, metabolic syndrome, and other human diseases, making it a compelling area of research. Advances in CRISPR-based gene editing and metabolomics now allow precise dissection of the enzymes, transporters, and regulatory networks involved in betaine metabolism. EDITGENE provides the tools and expertise to generate custom knockout, point-mutation, knock-in, and overexpression models for studying amino-acid betaine metabolic process. By combining rigorous experimental design with bioinformatics support, we help researchers translate mechanistic insights into therapeutic strategies.
References
- 1. Olivieri G et al.. 2026. First Revision of the Guidelines for the Diagnosis and Management of Remethylation Disorders.. J Inherit Metab Dis 49(4):e70177 PMID: 42231716
- 2. Zawieja E et al.. 2024. Betaine supplementation modulates betaine concentration by methylenetetrahydrofolate reductase genotype, but has no effect on amino acid profile in healthy active males: A randomized placebo-controlled cross-over study.. Nutr Res 127:63-74 PMID: 38876040
- 3. Blachier F et al.. 2020. Sulfur-Containing Amino Acids and Lipid Metabolism.. J Nutr 150(Suppl 1):2524S-2531S PMID: 33000164
- 4. Schweikhard ES et al.. 2012. Amino acid secondary transporters: toward a common transport mechanism.. Curr Top Membr 70:1-28 PMID: 23177982
- 5. Craig SA. 2004. Betaine in human nutrition.. Am J Clin Nutr 80(3):539-49 PMID: 15321791
- 6. Zeisel S. 2017. Choline, Other Methyl-Donors and Epigenetics.. Nutrients 9(5) PMID: 28468239
- 7. Zheng J et al.. 2021. Roles of amino acid derivatives in the regulation of obesity.. Food Funct 12(14):6214-6225 PMID: 34105579
- 8. Niu T et al.. 2023. Effects of exogenous glycine betaine and cycloleucine on photosynthetic capacity, amino acid composition, and hormone metabolism in Solanum melongena L.. Sci Rep 13(1):7626 PMID: 37165051
